Log in

NYSE:WATWaters Stock Price, Forecast & News

$212.34
+1.70 (+0.81 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$209.86
Now: $212.34
$212.85
50-Day Range
$174.76
MA: $200.63
$227.45
52-Week Range
$154.39
Now: $212.34
$245.68
Volume418,027 shs
Average Volume606,184 shs
Market Capitalization$13.15 billion
P/E Ratio26.44
Dividend YieldN/A
Beta0.99
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Read More
Waters logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.8Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.23 out of 5 stars


Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
CUSIP94184810
Phone508-478-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.41 billion
Cash Flow$11.20 per share
Book Value($3.10) per share

Profitability

Net Income$592.20 million

Miscellaneous

Employees7,500
Market Cap$13.15 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$212.34
+1.70 (+0.81 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Waters (NYSE:WAT) Frequently Asked Questions

How has Waters' stock been impacted by COVID-19 (Coronavirus)?

Waters' stock was trading at $184.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, WAT stock has increased by 15.3% and is now trading at $212.34.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Waters?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 4 sell ratings and 6 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Waters
.

When is Waters' next earnings date?

Waters is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Waters
.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) posted its quarterly earnings results on Tuesday, July, 28th. The medical instruments supplier reported $2.10 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.63. The medical instruments supplier had revenue of $519.98 million for the quarter, compared to analyst estimates of $519.41 million. Waters had a negative return on equity of 349.31% and a net margin of 22.61%.
View Waters' earnings history
.

What guidance has Waters issued on next quarter's earnings?

Waters issued an update on its second quarter 2020 Pre-Market earnings guidance on Wednesday, July, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $517-523 million, compared to the consensus revenue estimate of $485.38 million.

What price target have analysts set for WAT?

10 brokerages have issued twelve-month target prices for Waters' shares. Their forecasts range from $145.00 to $225.00. On average, they anticipate Waters' share price to reach $194.50 in the next twelve months. This suggests that the stock has a possible downside of 8.4%.
View analysts' price targets for Waters
.

Has Waters been receiving favorable news coverage?

Media coverage about WAT stock has trended very positive on Saturday, according to InfoTrie. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Waters earned a daily sentiment score of 4.0 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term.
View the latest news about Waters
.

Are investors shorting Waters?

Waters saw a decline in short interest in July. As of July 31st, there was short interest totaling 3,180,000 shares, a decline of 7.0% from the July 15th total of 3,420,000 shares. Based on an average trading volume of 655,400 shares, the short-interest ratio is currently 4.9 days. Currently, 5.2% of the shares of the stock are sold short.
View Waters' Current Options Chain
.

Who are some of Waters' key competitors?

What other stocks do shareholders of Waters own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Honeywell International (HON), Home Depot (HD), CVS Health (CVS), Raytheon Technologies (RTX), Alibaba Group (BABA), Verizon Communications (VZ), Cisco Systems (CSCO), Walmart (WMT) and CSX (CSX).

Who are Waters' key executives?

Waters' management team includes the following people:
  • Christopher James O'Connell, Chairman & CEO (Age 52)
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 52)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 55)
  • Mr. Francis S. Kim, Sr. VP of Global Operations (Age 52)
  • Mr. Robert G. Carson, Sr. VP of Corp. Devel. & Interim Pres of TA Bus. (Age 45)

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Who are Waters' major shareholders?

Waters' stock is owned by many different institutional and retail investors. Top institutional shareholders include Marathon Asset Management LLP (0.73%), Sumitomo Mitsui Trust Holdings Inc. (0.70%), Boston Trust Walden Corp (0.48%), Swiss National Bank (0.40%), New York State Common Retirement Fund (0.36%) and Robecosam AG (0.34%). Company insiders that own Waters stock include Christopher A Kuebler, Christopher J Oconnell, Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice.
View institutional ownership trends for Waters
.

Which major investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including Raymond James & Associates, Gateway Investment Advisers LLC, First Trust Advisors LP, Mountain Pacific Investment Advisers Inc. ID, New York State Common Retirement Fund, BI Asset Management Fondsmaeglerselskab A S, Harvey Investment Co. LLC, and Oregon Public Employees Retirement Fund. Company insiders that have sold Waters company stock in the last year include Christopher J Oconnell, Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, and Mark T Beaudouin.
View insider buying and selling activity for Waters
.

Which major investors are buying Waters stock?

WAT stock was purchased by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., PGGM Investments, Robecosam AG, Marathon Asset Management LLP, BNP PARIBAS ASSET MANAGEMENT Holding S.A., Robeco Institutional Asset Management B.V., Russell Investments Group Ltd., and Assenagon Asset Management S.A..
View insider buying and selling activity for Waters
.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $212.34.

How big of a company is Waters?

Waters has a market capitalization of $13.15 billion and generates $2.41 billion in revenue each year. The medical instruments supplier earns $592.20 million in net income (profit) each year or $8.99 on an earnings per share basis. Waters employs 7,500 workers across the globe.

What is Waters' official website?

The official website for Waters is www.waters.com.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.